Remove FDA Remove Licensing Remove World Health
article thumbnail

Where telemedicine is headed now that the PHE has ended

Healthcare IT News - Telehealth

This also happens to coincide with the World Health Organization declaring an end to the COVID-19 global health emergency. What can be expected in healthcare and health IT now that the PHE has ended, and what does this mean for the future of telehealth? The fact is nothing that dramatic happened on the day the PHE ended.

article thumbnail

Better Health Care Tests, Faster

Healthcare IT Today

Virax Biolabs uses data from the World Health Organization and others to develop tests quickly. Esquivel says, “ixlayer partners with CLIA-accredited laboratories and performs a rigorous vetting process of their validations protocols and operational capabilities from the licensing perspective on a state-by-state basis.

COVID-19 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Global Challenge of Unhealthy Diets: Front-of-Package Labeling for America

Bill of Health

Food and Drug Administration (FDA) is expected to propose new rulemaking on front-of-package labeling in 2024. The World Health Organization (WHO) has recommended FOP labeling as a cost-effective intervention to improve population-level dietary habits. Since 2009, the U.S. No standardized system exists but the U.S.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

Since health authorities have not yet published guidelines for a comprehensive control strategy specific to microbiological topics for ATMPs, it is up to the individual ATMP sponsor or license holder to apply these compendial references properly. United States Food and Drug Administration (FDA) – Regulations and guidance.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary for January and February 2024

SQA

The Administrative Measures are comprised of the following seven chapters, encompassing a total of 79 articles that mainly address the administration of drug supply licenses, obligations of businesses supplying drugs and medical institutions using drugs, as well as regulators supervision of stakeholders in drug supply and use.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary for March and April 2024

SQA

The adoption of these mechanisms is recommended and encouraged by the World Health Organization (WHO) so that the population has faster access to health services and technologies. CDSCO is looking to adopt the use of this guidance for premarket license applications and post-approval change applications. Kappin Ltd.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – July/August

SQA

Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. The counterfeit devices were sold online by a distributor named Healthful Plus without the required license to import, distribute, or sell medical devices in Canada. PDA Technical Report No.